dehydroftorafur: Clinical Trials

57 trials of dehydroftorafur, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 active not recruiting, 16 completed, 14 recruiting, 5 terminated. 57 Phase 2, 14 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 257Active not recruiting 17, Completed 16, Recruiting 14, Terminated 5, Unknown 2, Withdrawn 2, Not yet recruiting 1
Phase 114Completed 4, Recruiting 4, Active not recruiting 3, Not yet recruiting 1, Unknown 1, Withdrawn 1
Phase 32Active not recruiting 2

Follow dehydroftorafur: new trials by email Literature Review of dehydroftorafur trials Research Report on dehydroftorafur

Trials (filtered) newest first · largest first

All 57 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing Safe Doses of Anti-Cancer Medicines, 5-Flurouracil (5-FU) and Tretinoin (ATRA), Added to the Usual Cancer Treatment of Ependymoma
Biospecimen Collection, Echocardiography Test, Fluorouracil - Childhood Posterior Fossa Ependymoma
Phase 1 / Phase 2Not yet recruitingChildren's Oncology Group702026-12-112026-09-30
SMAD4 Tailored Neoadjuvant Therapy for the Treatment of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma, SMART-PANC Trial
Biospecimen Collection, Computed Tomography, Electronic Health Record Review - Borderline Resectable Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma
Phase 2RecruitingNorthwestern University1252026-10-262026-10-29
DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer
Biospecimen Collection, Computed Tomography, Dynamic Contrast-Enhanced Magnetic Resonance Imaging - Borderline Resectable Pancreatic Ductal Adenocarcinoma
Phase 1 / Phase 2RecruitingOhio State University Comprehensive Cancer Center502026-10-012026-10-05
Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy
Biospecimen Collection, Capecitabine, Diltiazem Hydrochloride - Malignant Digestive System Neoplasm
Phase 1 / Phase 2RecruitingMayo Clinic602026-04-302026-06-02
NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial
Biospecimen Collection, Computed Tomography, Fluorouracil - Borderline Resectable Pancreatic Ductal Adenocarcinoma
Phase 2RecruitingRoswell Park Cancer Institute202026-03-022026-09-21
Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8
Phase 1 / Phase 2RecruitingRoswell Park Cancer Institute352026-02-162026-08-19
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Biospecimen Collection, Cisplatin, Computed Tomography - Non-Muscle Invasive Bladder Urothelial Carcinoma, Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma
Phase 2RecruitingNational Cancer Institute (NCI)1602025-06-032026-11-09
FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery
Balstilimab, Biospecimen Collection, Botensilimab - Rectal Adenocarcinoma, Stage IIA Rectal Cancer AJCC v8
Phase 2RecruitingCity of Hope Medical Center262025-05-202026-06-29
Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer
Biopsy, Biospecimen Collection, Computed Tomography - Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma
Phase 2Active not recruitingMayo Clinic242024-12-062026-06-18
Testing the Efficacy of Topical Calcipotriene Plus 5-Fluorouracil Combination to Activate the Immune System Against Precancerous Skin Lesions in Organ Transplant Recipients
Biopsy, Calcipotriene, Fluorouracil - Actinic Keratosis
Phase 2Active not recruitingUniversity of Arizona562024-07-022025-09-24
Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)
Binimetinib, Biopsy Procedure, Biospecimen Collection - Advanced Biliary Tract Carcinoma, Advanced Gallbladder Carcinoma
Phase 2Active not recruitingNational Cancer Institute (NCI)182024-02-092026-11-12
Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer
Atezolizumab, Biospecimen Collection, Capecitabine - Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
Phase 2Active not recruitingNational Cancer Institute (NCI)22023-12-062026-07-01
Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma
Biospecimen Collection, Computed Tomography, Endoscopic Ultrasound - Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
Phase 2RecruitingMayo Clinic992023-11-212026-10-01
FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Microsatellite Stable (MSS) Metastatic Colorectal Cancer
Balstilimab, Bevacizumab, Biospecimen Collection - Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma
Phase 1 / Phase 2Active not recruitingCity of Hope Medical Center202023-05-032026-09-01
New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study
Cisplatin, Fluorouracil, Gemcitabine - Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma
Phase 2WithdrawnM.D. Anderson Cancer Center2023-04-182026-05-04
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Alpelisib, Binimetinib, Biopsy Procedure - Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8
Phase 2RecruitingNational Cancer Institute (NCI)29002023-04-072026-11-18
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
Biospecimen Collection, Computed Tomography, Devimistat - Advanced Biliary Tract Carcinoma, Advanced Colorectal Carcinoma
Phase 2RecruitingNorthwestern University942023-03-082023-03-10
Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma
Biopsy, Biospecimen Collection, Computed Tomography - Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8
Phase 2RecruitingRoswell Park Cancer Institute402023-03-072025-12-16
Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
Biospecimen Collection, Computed Tomography, Core Biopsy - Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma
Phase 1 / Phase 2RecruitingJonsson Comprehensive Cancer Center1412023-03-072026-11-09
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
Anoscopy, Biospecimen Collection, Capecitabine - AIDS-Related Anal Carcinoma, Anal Margin Squamous Cell Carcinoma
Phase 2Active not recruitingNational Cancer Institute (NCI)402022-08-092026-11-18

Showing 20 of 57. Sign in to see all of them.

Conditions studied

Pancreatic Neoplasms (12)  ·  Rectal Neoplasms (6)  ·  Anus Neoplasms (4)  ·  Colorectal Neoplasms (4)  ·  Adenocarcinoma Of Esophagus (3)  ·  Colonic Neoplasms (3)  ·  Urinary Bladder Neoplasms (3)  ·  Anal Canal Carcinoma (2)  ·  Carcinoma, Hepatocellular (2)  ·  Cholangiocarcinoma (2)  ·  Esophageal Neoplasms (2)  ·  Gallbladder Neoplasms (2)  ·  Gastrointestinal Neoplasms (2)  ·  Klatskin Tumor (2)  ·  Ovarian Neoplasms (2)

Sponsors

National Cancer Institute (NCI) (15)  ·  M.D. Anderson Cancer Center (7)  ·  Mayo Clinic (5)  ·  Roswell Park Cancer Institute (5)  ·  City of Hope Medical Center (3)  ·  ECOG-ACRIN Cancer Research Group (3)  ·  University of Nebraska (3)  ·  NRG Oncology (2)  ·  Northwestern University (2)  ·  OHSU Knight Cancer Institute (2)  ·  SWOG Cancer Research Network (2)  ·  Academic and Community Cancer Research United (1)  ·  Albert Einstein College of Medicine (1)  ·  Barbara Ann Karmanos Cancer Institute (1)  ·  Children's Oncology Group (1)

Countries

United States (55)  ·  Canada (4)  ·  Puerto Rico (4)  ·  Australia (1)  ·  China (1)  ·  Hong Kong (1)  ·  Norway (1)  ·  Singapore (1)  ·  Taiwan (1)

Top investigators

Christos Fountzilas (2)  ·  Mariela Blum (2)  ·  Marwan Fakih (2)  ·  Adam J Esbenshade (1)  ·  Anthony Shields (1)  ·  Ardaman Shergill (1)  ·  Brett L Ecker, MD (1)  ·  Brian C Baumann (1)  ·  Cathy Eng (1)  ·  Charles D Lopez (1)  ·  Chi Lin (1)  ·  Chi Lin, MD, PhD (1)  ·  Christopher L. Hallemeier, MD (1)  ·  Darren Feldman (1)  ·  Davendra Sohal (1)

Results publications

PMID 22178121, PMID 25926352, PMID 27978579, PMID 32740235, PMID 32939319, PMID 33475684, PMID 33835977, PMID 34196693, PMID 34272087, PMID 34980020, PMID 36221952, PMID 36963200, PMID 37266942, PMID 37478389, PMID 38445914, PMID 39938471, PMID 41133726

NIH funding

U10CA180820 (7), U10CA180888 (5), U10CA180868 (4), P30CA036727 (3), P30CA033572 (2), P30CA060553 (2), U10CA021661 (2), U10CA032102 (2), U10CA180821 (2), N01CM00071 (1), N01CM62201 (1), N01CM62206 (1), P01CA084203 (1), P30CA008748 (1), P30CA013330 (1)